Search
Cyclizine
go.drugbank.com/drugs/DB01176ApprovedWithdrawnA histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935)
Aficamten
go.drugbank.com/drugs/DB18490ApprovedInvestigationalAficamten is a cardiac myosin inhibitor. Approved by the FDA on December 19, 2025, aficamten is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symp...
Olodaterol
go.drugbank.com/drugs/DB09080ApprovedInvestigationalTreatment with bronchodilators helps to mitigate associated symptoms such as shortness of breath, cough, and sputum production. … A once-a-day treatment with a LABA has several advantages over short-acting bronchodilators and twice-daily LABAs including improved convenience and compliance and improved airflow over a 24-hour period
Bryostatin 1
go.drugbank.com/drugs/DB11752InvestigationalBryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease.
GSK-690693
go.drugbank.com/drugs/DB12745InvestigationalGSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma.
Amithiozone
go.drugbank.com/drugs/DB12829InvestigationalAmithiozone has been used in trials studying the treatment of Mycobacterium Avium-intracellulare Infection.
DA-6886
go.drugbank.com/drugs/DB12853InvestigationalDA-6886 has been used in trials studying the treatment of Irritable Bowel Syndrome.
Ingavirin
go.drugbank.com/drugs/DB11944InvestigationalIngavirin has been used in trials studying the treatment of Influenza and Common Cold.
Apabetalone
go.drugbank.com/drugs/DB12000InvestigationalApabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.
N-6022
go.drugbank.com/drugs/DB12206InvestigationalN6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis.